References

Typical assignments

  • Regulatory medical writing via CRO for a global pharmaceutical company on immunotherapeutic substances,
  • Writing of Investigator Brochures, reports on in vitro and in vivo preclinical studies for SMEs and CROs, and summaries of meetings of a platform involved in the development of cancer drugs,
  • Writing of papers for scientific journals, e.g. on innovative oncology trial design, the role of pharmacology in anticancer drug development, and pharmacogenomics characterisation of a targeted agent,
  • Consulting in non-clinical development of oncology therapeutic agents for a global healthcare company, and the non-clinical and early clinical development of an arsenic anticancer drug of an SME,
  • Due diligence support- evaluating potential anticancer drugs
  • Coaching of a Max-Delbruck Centre-funded project,
  • Review of Eurostars, ERC, ESF and BIH grant proposals,
  • Review of manuscripts for scientific journals.

Recent publications

Recent lectures

  • Hendriks HR. Preclinical drug development in oncology. Educational lecture, Finnish prclinical CRO, December 2019
  • Hendriks HR. Drug development, after the NCI-compounds initiative. Educational course: preclinical and early-phase clinical pharmacology. 40th EORTC-PAMM Winter meeting, Verona, 6 February, 2019.
  • Hendriks HR. New Types of Clinical Studies. Educational course: Preclinical and early-phase clinical pharmacology. 40th EORTC-PAMM Winter meeting, Verona, 6 February, 2019.
  • Hendriks HR. Pharmacology directed strategies in anticancer drug development, a viable approach for academia? Turku Cancer Research Society & Western Cancer Centre FICAN West, Cancer Seminar Series, Turku, Finland, 4 September 2018.